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Abstract Lead is a major environmental toxicant throughout the world. Lead can induce severe neurotoxicity including
irreversible hearing impairment. Many in vivo studies have shown that lead damages the auditory nervous system,
but has little or no effect on cochlear sensory hair cells. To gain insights on lead ototoxic and neurotoxic effects
in vitro, lead acetate (LA) was applied to postnatal day 3-4 rat cochlear organotypic cultures for 24 or 72 h with
doses of 0.1, 0.5,1, 2 or 4 mM. After 24 or 72 h treatment with lead acetate, nearly all of cochlear sensory hair cells
were intact. However, after 72 h treatment, the peripheral auditory nerve fibers projecting to the hair cells and the
spiral ganglion neurons (SGN) were damaged when lead concentration exceeded 2 mM. Our results indicated that 72
h treatment with only the high doses (> 2 mM) of lead actate damaged SGNs and peripheral nerve fibers; hair cells
remained structurally intact even after 4 mM treatment. These results show that lead primarily damages cochlear
nerve fibers andSGNratherthanhaircells.
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Introduction
Industrial pollution describes the introduction of foreign
substances into the biosphere. Many heavy metals, such
as lead, mercury, nickel, zinc, cadmium, chromium and
manganese, 1-6 can invade the human system through
the food chain to cause multiple toxicities. The most
adverse effects of these heavy metals on the nervous
system give rise to neurotoxicity.
Lead is one of the oldest-established poisons in
heavy metals, and continues to be a major public health
problem throughout the world. The toxic effects of lead
were involved in learning impairment, 7 cognitive and
behavioral deficits, 8 as well as hearing impairment.9, 10
In the auditory system, lead can result in decrease of
auditory evoked potentials and auditory sensitivity by
demyelinization and axonal degeneration in the autitory
nervous system. 9-12 In addition, the developing central
nervous system is particularly more susceptible to
environmental lead exposure than adult. 13, 14
In the central auditory system, the neurotoxic effects
of lead can be detected in many portions in central audi⁃
tory pathway. After acute treatment of lead, significant
reduction of glucose metabolism is detected in the medial
geniculate bodies, inferior colliculus and auditory
cortex. 15 The results in previous studies demonstrate
that lead exposure can alter the neuronal structural
proteins by increasing phosphorylations in both medium
and high-weight forms of neurofilament, which impairs
the axonal transport and results in impairments of
temporal processing within the auditory brainstem. 15, 16
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In addition, VMAT2, 5-HT, and DβH expression in the
superior olivary complex can also be significantly
reduced by low dose lead treatment. 17 Since the medial
geniculate bodies, inferior colliculus and auditory
cortex belong to the auditory afferent system, while the
superior olivary complex is the location of cochlear ef⁃
ferent neurons. Above evidence therefore suggests that
the neurotoxic actions of lead can affect both afferent
and efferent nervous systems in the central auditory
pathway.
In the peripheral auditory system, many in vivo stud⁃
ies have demonstrated that lead treatment can cause a
significant threshold elevation and a latency prolonga⁃
tion in compound action potential (CAP). 18, 19 However,
the endocochlear potential (EP) shows no change. 18 and
the distortion product otoacoustic emissions (DPOAE)
and the cochlear microphonics (CM) remain normal,
suggesting that lead in vivo systemic treatment can only
impair the peripheral auditory nervous system, but
spares the cochlear sensory hair cells and the stria
vascularis .18, 19 However, it is unknown if lead can in⁃
jure the peripheral auditory system in cochlear organo⁃
typic cultures. The purpose of this study was to investi⁃




Cochlear organotypic cultures were prepared from post⁃
natal day 3 SASCO Sprague Dawley rats as described pre⁃
viously 5. Briefly, to establish a collagen gel matrix, a
drop (15μl) of cool rat tail collagen (Type 1, Collabora⁃
tive Biomedical Products #40236) together with a mix⁃
ture of 3.76 mg/ml in 0.02 N acetic acid, 10×basal me⁃
dium eagle (BME, Sigma B9638), and 2% sodium car⁃
bonate at a 9:1:1 ratio were placed at the center of a 35
mm diameter culture dish (Falcon 1008, Becton Dickin⁃
son) and allowed to form a gel at room temperature for
approximately 30 min. When the collagen gel matrix
is prepared, 1.3 ml of serum-free medium consist⁃
ing of 2g bovine serum albumin (BSA, Sigma
A-4919),2mlSerum-Free Supplement (Sigma I-1884),
4.8 ml of 20% glucose (Sigma G-2020), 0.4 ml peni⁃
cillin G (Sigma P-3414), 2 ml of 200 mM glutamine
(Sigma G-6392), 190.8 ml of 1×BME (Sigma B-1522)
were added to the dish. Sprague-Dawley rat pups at
postnatal day 3 were decapitated, and the cochleae
were carefully removed in Hank’s Balanced Salt Solu⁃
tion (1X GIBCO, 14175, Invitrogen, Carlsbad, CA). The
cochlear lateral wall and auditory nerve bundle in the
center of modiolus were dissected away respectively
and the whole basilar membrane containing the organ of
Corti and SGNs was transferred onto a collagen gel
matrix as a flat surface preparation. The cochlear
explants were maintained in an incubator at 37°C and
5% CO2 overnight. On the following day, fresh medium
with or without various concentrations of lead was
added.
Lead acetate treatments
On the second day, cochlear explants (n=6/group) were
treated with lead acetate (Sigma-316512) at concentra⁃
tions of 0.1 mM, 1 mM, 2 mM, or 4 mM in standard
culture medium for 24 h or 72 h. The cochlear explants
from the normal control groups were cultured in the
same standard culture medium without lead acetate for
same period of 24 h or 72 h respectively.
Histological evaluation
At the end of the experiment, cochlear explants were
fixed for 1 h in 10% formalin and subsequently washed
with 0.1 M PBS. Cochlear cultures were immersed in a
solution containing a monoclonal antibody against
neurofilament 200 (Sigma N0142, clone N52) for 48
hours at 4 °C. The antibody was diluted 1:100 in blocking
solution containing 1% Triton X-100 and 3% goat
serum in 0.1M PBS. The specimens were rinsed with
0.01 M PBS three times and incubated for 1 h with a
secondary antibody, goat anti-mouse IgG, (Sigma
T5393) labeled with TRITC in centuplicate dilution. To
visualize F-actin that is heavily expressed in the cu⁃
ticular plate and stereocilia bundles of hair cells, speci⁃
mens were labeled with Alexa 488-labeled phalloidin
(Invitrogen A12379, diluted by 1:200) for 30 min. After
rinsing with 0.1 M PBS, specimens were mounted on
glass slides in glycerin, coverslipped and examined un⁃
der a confocal microscope (Zeiss LSM-510 meta).
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To detect the apoptotic signals in lead treated cochlear
explants, 5 cochleae were cultured in standard culture
medium without lead for 72 h as normal controls, while
another 5 cochlear cultures were treated with 2 mM
lead for 72 h. A kit of APO-BrdU™ TUNEL Assay
(Invitrogen, A23210) was used to detect apoptotic cells
according to the manufacturer’s instructions. After fixa⁃
tion and staining with a monoclonal antibody against
neurofilament 200 as described above, the samples
were incubated in the 100 μl DNA-labeling solution
(containing 20 μl reaction buffer, 1.5 μl TdT enzyme,
16 μl BrdUTP and 62.5 μl dH2O) at 37°C for 4 h. After
washing in the rinse buffer, the cultures were incubated
in 100 μl antibody solution (containing 5.0 μl the
Alexa FluorR 488 dye-labeled anti-BrdU antibody and
95 μl rinse buffer) for 1 h at room temperature. Speci⁃
mens were then rinsed with 0.01 M PBS and mounted
on glass slides in glycerin and coverslipped.
Confocal microscopy
Specimens were examined under a confocal micro⁃
scope (Zeiss LSM-510 Meta) using appropriate filters
to detect the fluorescence of TRITC labeled product in
auditory nerve fibers and SGNs (excitation 550 nm,
emission 570 nm) and green fluorescence of Alexa
488-labeled phalloidin (excitation 488 nm, emission
520 nm) on the bundles of stereocilia and the cuticular
plate of the hair cells, or green fluorescence of Alexa
FluorR 488 dye-labeled anti-BrdU antibody in apoptot⁃
ic cells. Confocal images were processed using Confo⁃
cal LSM Image Examiner and Adobe Photoshop 5.5 soft⁃
ware. Representative confocal photomicrographs illus⁃
trating typical morphology were taken from the middle
of each basilar membrane. The amount of SGN shrink⁃
age and the SGN size were examined with Confocal
LSM Image Examiner as described previously. 20 In
brief, multiple layers of the images were first merged
into a single layer. The number of layers merged was
determined using two criteria: (1) the number of lay⁃
ers was maximized so that the largest cross sectional
area of each SGN was included in analysis and (2)
the overlap among different SGN was minimized. A
polygon was drawn around the perimeter of the cell
body of all distinguishable SGN and the Zeiss LSM
Image Examiner (version: 4,0,0,91) automatically calcu⁃
lated the enclosed area. Data were evaluated for statistical
significance with SigmaStat (version 3.5.0.54). All
quantitative data were evaluated for statistical signifi⁃
cance with SigmaStat (version 3.5.0.54).
Cochleograms
A cochleogram was used to determine the percentage
of IHC and OHC as a function of percent distance from
the apex to the base as described previously. [5] Cochlear
hair cells were counted at 0.24 mm intervals along the
entire length of the basilar membrane from apex to base
under a fluorescent microscope with the appropriate
filter to visualize the stereocilia and cuticular plate of
hair cells stained with Alexa 488-labeled phalloidin
(400 × , Zeiss Axioskop). A mean cochleogram showing
the percent IHC and OHC loss was constructed for each
group (6 cochleae from the normal control group after
72 h culture and 6 after 72 h treatment with 2 mM
lead). Using lab norms, the cochleogram showing the
percent hair cell loss as a function of percent distance
from the apex was constructed for each experimental
condition.
This research was approved by the University of
Buffalo Institutional Animal Care and Use Committee
in accordance with NIH guidelines.
Results
Damages in auditory nerve fibers and SGNs
In normal control cochleae cultured for 24 h, cochlear
hair cells were intact and the nerve fibers radically
projected toward the hair cells (Fig. 1A). SGNs had
large, round or oval shaped soma with thick nerve fibers
projecting from the soma (Fig. 1F). Three rows of OHC
and one row of IHC were present in all control and lead
acetate treated groups (Fig. 1A-1E). The auditory nerve
fibers maintained their normal structures in cultures
treated with lead at concentrations of 0.1 mM, 1 mM, 2
mM, and 4 mM for 24 h (Fig. 1B-1E). SGNs were intact
at lead concentrations ranging from 0.1 mM to 2 mM,
(Fig. 1F-1I). However, obvious shrinkage of SGN soma
was detected in 24 h lead treatment at 4 mM (Fig. 1J),
suggesting that lead-induced degeneration in peripheral
nervous system may start at the cell body of SGNs.
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Figure 1. Representative confocal photomicrographs of normal control and lead-treated cochleae after24 h culture. The hair cells are
stained with Alexa 488-labeled phalloidin (green), and the auditory nerve fibers and SGNs are labeled with a monoclonal antibody
against neurofilament 200 (red). Three rows of OHC and one row of IHC and auditory nerve fibers projecting cochlear hair cells appear
normal (A-E). SGNs are also normal in normal control and after lead treatment at concentrations of 0.1 mM, 1 mM, and 2 mM (F-I). SGN
shrinkage appears in cultures treated with lead at the concentration of 4 mM (J). (OHC: outer hair cells; IHC: inner hair cells; NF: nerve
fibers; SGN: spiral ganglion neurons. Scale bar: 15μm).
In normal control cochleae and cochleae treated with lead acetate for 72 h, all cochlear hair cells were intact (Fig.
2A-2E). However, many auditory nerve fibers were evidently damaged and the density of nerve fibers were greatly
decreased after 72 h of lead treatment at 2 and 4 mM (Fig. 2D, 2E). Obviously, the soma of SGNs were condensed or
fragmented when the concentration of lead exceeded 2 mM (Fig. 2I, 2J).
Figure 2 Representative confocal photomicrographs in normal control cochlea and lead acetate-treated cochleae after 72 h culture.
Normal control cochleae (A) and cochleae treated with lead acetate at 0.1 mM (B) and 1 mM (C) present normal cochlear hair cells and
auditory nerve fibers. In contrast, at lead concentrations of 2 mM or higher, the number of auditory nerve fibers is greatly reduced with
significant damage, although the cochlear hair cells are intact (D, E). SGNs are intact in normal control cochlea and in those treated with
0.1 and 1 mM lead acetate (F, G, H), whereas the soma of SGNs is greatly condensed at 2 mM lead acetate treatment (I). More serious
damages are visible in SGNs when the concentration of lead acetate reaches 4 mM (J). (OHC: outer hair cells; IHC: inner hair cells; NF:
nerve fibers; SGN: spiral ganglion neurons. Scale bar: 15μm).
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Quantification of cochlear hair cells
Comparison of cochleograms between normal control
and 2 mM lead acetate treated groups showed that most
cochlear hair cells were intact except for the extreme
base of the basilar membrane in the hook region (Fig
3A, 3B). Since missing hair cells were also found at the
basal hook region in normal control cochlear explants,
they were attributed to the mechanical damage by
cochlear microdissections. However, the number of hair
cells in the region from 80% to the apex until the base
was in normal range in both normal control and 2 mM
lead acetate treated groups (Fig 3A, 3B), indicating no
damage to the cochlear sensory hair cells by lead treat⁃
ment, which is consistent with previous in vivo findings.
Since there was no evidence of missing hair cells by 72
h lead acetate treatment at other concentrations, the
data of cochleograms from those groups (0.1 mM, 1 mM,
and 4 mM) were not shown.
Lead-induced SGN shrinkage
The size of SGNs in normal control cochleae ranged from 150 μm2 to 250 μm2 72 h after culture, with the peak val⁃
ue at 200 μm2 (Fig. 4A). The soma size in most SGNs was nearly normal and similar to the control SGNs after 72 h of
treatment with 1 mM lead acetate (Fig. 4B). However, when the concentration of lead acetate exceeded 2 mM, the
distribution of SGN soma area gradually shifted towards small values along with increase in lead acetate dose (Fig.
4C, 4D). At 1 mM, the peak SGN area decreased to 100-140 μm2 after 72 h lead acetate treatment (Fig. 4C). More⁃
over, the size in most SGN soma shrunk to 50-80 μm2, when the dose of lead acetate was increased to 4 mM (Fig.
4D).
Figure 3 Averaged cochleograms showing the percentage of IHC (solid line) and OHC (dashed line) loss in the control group (A) and
the group treated with 2 mM LA for 72 h (B). The mean loss of OHC and IHC was generally less than 5% in the treatment group along the
basilar membrane from apex to 80% distance from apex.
Figure 4 Distribution of SGN soma size in control group and groups treated with 1, 2 or 4 mM lead acetate for 72 h. In normal controls.
the peak of SGN soma size shows a mode near 200 μm2. The peak of SGN size in cochleae treated with 1 mM lead acetate is similar to
that of normal controls. For those that have been treated with lead acetate at 2 mM for 72 h, the peak of SGN size has moved to 120 μm2.
With lead acetate treatment at 4 mM for 72 h, more cell shrinkage has occurred and the major peak of SGN soma size is shifted to 70 μm2.
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Figure 5 shows the mean size of SGN soma (±SEM) in control group and groups treated with 1mM, 2 mM, and 4
mM lead acetate for 72 h. The data definitely indicated a dose dependent decrease in SGN soma area caused by lead,
when the concentration of lead acetate exceeded 2 mM. The statistical analysis revealed a significant difference in
SGN size between control group and groups treated with 2 mM or 4 mM lead (P<0.0001). The difference between 2
mM lead treated group and 4 mM lead treated group was also significant (P<0.0001, Newman-Keuls Multiple
comparison test). However, the difference between the control group and group treated with 1 mM lead was not significant
(P>0.05).
Figure 5 Comparison of mean SGN soma size (±SEM) among
the control and lead acetate treated cultures at concentra⁃
tions of 1 mM, 2 mM, and 4 mM for 72 h. The differences
between the control and lead treated groups at 2 mM and 4
mM, and between the 2 mM lead treated group and 4 mM
lead treated group are statistically significant (**P<0.0001),
whereas the difference between the control group and 1 mM
lead treated group is not (P>0.05) (Newman-Keuls Multiple
comparison test).
Lead-induced SGN death
The condensation or shrinkage or fragmentation of cell nuclei are considered to be the feature of apoptosis. Specific
apoptotic differential features were found in SGNs treated with lead acetate (Fig. 1J, Fig. 2H, 2I, 2J). Apoptotic
signals were tested by TUNEL labeling to confirm that those condensed SGNs were indeed undergoing apoptosis. Figure
6 shows negative TUNEL staining in normal control SGNs (Fig. 6A). However, positive TUNEL labeling was found in
some SGNs with pathological shrinkage that was treated with 2 mM LA for 72 h (Fig. 6B).
Figure 6 Typical confocal photomicrographs of SGNs double labeled with TUNEL staining (green) and neurofilament 200 antibody
(red). A: absence of TUNEL labeling in normal control SGNs; B: TUNEL positive labeling detected in degenerating SGNs which has
been cultured with 2 mM lead acetate for 72 h. (SGN: spiral ganglion neurons. Scale bar: 15μm).
··48
Journal of Otology 2011 Vol.6 No.2
Discussion
Many heavy metals are toxic as a consequence of
long period of excessive exposure via food, drinking
water, occupational exposure, etc. 19, 21-23 Therefore, the
occurrence of neurotoxic effects of heavy metals usually
takes time as their concentrations in the nervous system
accumulate to adverse effect levels over long-term
systemic exposure. For testing heavy metal neurotoxic
effects in experimental settings, it is difficult to fully
imitate the accumulative process in animals as real
exposure in nature. However, it is possible to shorten
the long period exposure in vitro by increasing the
concentration of heavy metals in the culture dish .5, 24 In
the present study, the designated high concentrations of
lead acetate applied to cochlear organotypic cultures
effectively induced neuronal degenerations at as early
as 24 or 72 h post-lead exposure.
Although it is well known that lead exposure can
damage hearing ,9-14, 18, 19 the present study is the first
investigation into potential neurotoxic effects of lead
acetate in the cochlear organotypic culture system. Neu⁃
ronal cell death is a major morphological change
observed in many neuropathological conditions, includ⁃
ing diabetic neuropathies, demyelinating diseases, and
neurodegenerative diseases such as auditory neuropa⁃
thy. In the current in vitro study, high doses lead treat⁃
ment is seen to selectively destroy SGNs while sparing
the cochlear sensory hair cells. This phenomenon is
consistent with previous in vivo findings showing that
systemic lead treatment do not alter DPOAEs or CM,
which are believed to be produced by cochlear outer
hair cells. However, lead injection efficiently reduces
the compound action potential (CAP), which is produced
by auditory nerve fibers of the SGN. According to some
reports, neuronal supporting cells such as glial cells
may segregate lead to protect neurons. However, their
protective actions do not last if the concentration of lead
is high. [24] This may help explain the short period of
resistance of SGNs against lead injury in the first 24 h,
and neuronal damage by lead treatment of long dura⁃
tions.
In many experimental models of hearing for cochlear
research, ototoxic drugs such as gentamicin are shown
to selectively destroy cochlear outer hair cells .25 In
contrast, carboplatin, a platinum agent, selectively
damages the inner hair cells in chinchilla .26, 27 However,
some ototoxic agents, such as manganese or cisplatin
can injure both cochlear sensory hair cells and SGNs
simultaneously .5, 28 In contrast to the above experimental
models, lead acetate treatment produces an unusual
lesion model in which the SGNs are selectively
destroyed without injury to cochlear sensory hair cells.
This model may be potentially interesting to people who
study auditory neuropathy and need a culture system
that creates degeneration in auditory peripheral neurons
with no effect on cochlear hair cells.
Lead toxicity is involved in disruption of cellular
energy metabolism, which results in the energy crisis
and finally excites multiple apoptotic signals .29 The
neurotoxic mechanism of lead is considered to be
caused by its ability to substitute with other particular
polyvalent cations such as calcium (Ca2+) and zinc (Zn2+)
at their original binding sites. These substitutions allow
lead to have the potential to affect different biological
processes, including metal transport, energy metabo⁃
lism, apoptosis, excitotoxicity, oxidative stress, signal⁃
ing changes of neurotransmitters, diverse enzymatic
processes, protein maturation and genetic regulation. In
this study, we found that many SGNs were condensed or
shrunkwithpositiveTUNELlabelingafter72hof culturing
with high concentrations of lead acetate. This indicates
that lead-inducedSGNsdeathoccurs largelyby apoptosis.
However, the exact apoptotic pathways and degenerative
mechanisms by lead treatment in cochlear organotypic
cultures remain to be further studied.
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